4. Study results grouped by outcome measures and interventions – cough augmentation therapy compared to standard care.
Outcome measure |
Study identifier Sample size Data presentation |
Unassisted cough | Manual BS | Standard care | Between‐group differences |
Number and duration of unscheduled hospital and ICU admissions |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
Unassisted PCF |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
Health‐related quality of life |
Katz 2019 n = 67 Pediatric Quality of Life Inventory score |
— | Not reported | Not reported | No results reported |
FVC |
Katz 2019 n = 67 Median % predicted |
85.5 (entire cohort)a | 4.1% change | 6.4% change | Adjusted MD 2.0, 95% CI –8.2 to 12.3 |
Time to 10% decline in FVC |
Katz 2019 n = 67 Not reported |
— | Data not reported | Data not reported | Manual BS vs standard care: P = 0.5 |
Maximal inspiratory or insufflation capacity |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
MEP |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
MIP |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
Number and duration of outpatient oral antibiotic courses |
Katz 2019 n = 67 Units not specified |
— | Not reported | Not reported | No results reported |
BS: breathstacking; CI: confidence interval; FVC: forced vital capacity; ICU: intensive care unit; MD: mean difference; MEP: maximal expiratory pressure; MIP: maximal inspiratory pressure; n: number of participants; PCF: peak cough flow.
aBaseline value – not a randomly assigned control